Lee currently heads the cell therapy global supply chain at Bristol Myers Squibb, orchestrating the planning and delivery of CAR-T therapies. With a keen focus on integrating services, mitigating risks, and managing portfolios, he adeptly oversees both strategic and day-to-day operational aspects, optimizing clinical and commercial supply chains. Lee’s professional journey started in the defense industry as an engineer before transitioning to a supply chain role within the fast-moving consumer goods textile industry. Over a decade ago, he transitioned to the life sciences sector, where he has excelled in global strategy development, product launches, and operational excellence initiatives for both biologics and small molecules. Throughout his career, Lee has been a driving force behind collaboration, continuous improvement, and the achievement of impactful results.